STORM Therapeutics
Paul is Harrap Professor of Pharmacology and Therapeutics at the Institute of Cancer Research (ICR), as well as the former Head of the Division of Cancer Therapeutics Division of Cancer Therapeutics and former Director of the Cancer Research UK Cancer Therapeutics Unit from 1997-2016.
A leader in the field of molecularly targeted cancer drugs, he is a Fellow of the Royal Society, Academy of Medical Sciences, the Royal Society of Medicine, the Royal Society of Chemistry and the Royal Society of Biology and is a Cancer Research UK Life Fellow. Paul's research focus is the discovery and development of cancer drugs that exploit our knowledge of the cancer genome and cancer biology and his passion is personalised medicine.
This person is not in the org chart
This person is not in any offices
STORM Therapeutics
1 followers
STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.